Referencias
1 Liver Cancer/Nexavar Marketing Document. 2008.
2 Thuluvath PJ,Choti M, Geschwind JF, Norwitz L and Kalloo AN. About Liver Cancer. Johns Hopkins Liver Cancer Center. http://gastro.nts.jhu.edu/about.cfm.
3 Guyton A and Hall J. The Liver as an Organ. Chapter 70. In: Textbook of Medical Physiology. 10th. edition. Philadelphia
4 Available at University of Southern California: http://www.surgery.usc.edu/divisions/hep/patientguide/whattheliverdoes.html
5 Available at American Society of Clinical Oncology: http://www.asco.org/patient/Cancer+Types/Liver+Cancer
6 Forner A, Hessheimer AJ, Isabel Real M, Bruix J. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol. 2006; 60: 89- 98.
7 Jemal A, Siegal R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57 (1): 43- 66.
8 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907– 1917.
9 Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004; 5:215- 219.
10 Hall AJ and Wild CP. Liver cancer in low and middle income countries. BMJ 2003; 326; 994-995.
11 Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1): S87-96.
12 Ghassan AA. Hepatocellular Carcinoma: Molecular Biology and Therapy. Semin Oncol 2006;33(6 Suppl 11):S79-S83.
13 Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet. 1999; 353: 1253- 1257.
14 Available at Mayo Clinic: http://www.mayoclinic.com/health/hepatitis-b/DS00398/DSECTION=prevention
15 Davila JA, Morgan RO, Shaib Y, et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004; 127: 1372- 1380.
16 Tanaka Y, Hanada K, Mizokami M, et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002; 99: 15584- 15589.
17 Giordano TP, Kramer JR, Souchek J, Richardson P, El Serag HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004;164:2349-2354.
18 Available at Centers for Disease Control and Prevention (CDC): http://www.cdc.gov/hepatitis/index.htm
19 Qian Y, Fan JG. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int. 2005; 4(2): 173- 177.
20 Available at Mayo Clinic: http://www.mayoclinic.com/health/nonalcoholic-fatty-liver-disease/DS00577
21 Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005;11:7391-400.
22 Davila, JA, Morgan, RO. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. GUT . 2005;54:533-539. Available at: http://gut.bmj.com/cgi/content/abstract/54/4/533
23 Veldt, B., Chen, W. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology. 2008; 1856-1862.
24 Bruix J and Sherman M. Management of Hepatocellular carcinoma. Hepatology 2005;42:1208-36.
25 Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E
Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. World J Gastroenterol. 2006 Dec 7;12(45):7239-49.
26 Zhu AX. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? The oncologist 2006;11:790-800.
27 American Liver Foundation “Debunking Liver Disease Myths.” Last updated October 24, 2007. Available at: http://www.liverfundation.org/chapters/newengland/news/150/
28 American Liver Foundation Web site. Available at: http://www.liverfoundation/org/education/info/progression/
29 WebMd. Available at: http://www.webmd.com/cancer/understanding-liver-cancer-basic-information
